
Publications
Articles et résultats scientifiques des équipes et collaborateurs du PGNM.
À propos
Les publications du PGNM reflètent la production scientifique des équipes et des collaborateurs du laboratoire, couvrant les mécanismes fondamentaux, les modèles de maladies, les technologies et la recherche translationnelle.
2024
Serotonin reuptake inhibitors improve muscle stem cell function and muscle regeneration in male mice,
Nature Communications.
2024
Keep calm and reboot – how cells restart transcription after DNA damage and DNA repair,
FEBS Lett 2025 Jan; 599(2): 275-294.
2024
Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for In Vivo Mouse Studies.,
J Med Chem 2024 Jul; 67(13): 11296-11325.
2024
Different Founding Effects Underlie Dominant Blue Eyes (DBE) in the Domestic Cat,
Animals.
2024
The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis.,
Brain 2024 May; 147(5): 1768-1783.
2024
LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal.,
Nucleic Acids Res 2024 Apr; 52(7): 3667-3681.
2024
A PAX3 insertion in the Celestial breed and certain feline breeding lines with dominant blue eyes,
Animal Genetics.
2024
H2A.Z is involved in premature aging and DSB repair initiation in muscle fibers,
Nucleic Acids Res 2024 Apr; 52(6): 3031-3049.
2024
Neurofilaments: Novel findings and future challenges.,
Curr Opin Cell Biol 2024 Apr; 87(): 102326.
2024
miR-218-5p and doxorubicin combination enhances anticancer activity in breast cancer cells through Parkin-dependent mitophagy inhibition,
Cell Death Discovery.
2024
The AMPK-related kinase NUAK1 controls cortical axons branching by locally modulating mitochondrial metabolic functions,
Nature Communications.
2024
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?,
Cells.
2024
The sweet side of glia-to-neuron reprogramming,
.
2024
Enhanced capacity for CaMKII signaling mitigates calcium release related contractile fatigue with high intensity exercise.,
Biochim Biophys Acta Mol Cell Res 2024 Feb; 1871(2): 119610.
2024
Decline of DNA damage response along with myogenic differentiation,
Life Sci Alliance 2024 Feb; 7(2): .
2024
Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia,
Trends in Molecular Medicine.
2024
Neuronal Autophagy: Regulations and Implications in Health and Disease.,
Cells 2024 Jan; 13(1): .
2024
Combining doxorubicin and miR-218-5p: a new strategy to fight breast cancer?,
Autophagy Reports.
2024
Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments,
Cell Metabolism.
2024
A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia,
Biochim Biophys Acta Mol Cell Res 2024 Oct; 1871(7): 119809.